Exfoliation and related microstructures in 2024 aluminum body skins on aging aircraft

Exfoliation, a directional attack along elongated grain boundaries, has been examined in some detail in rolled 2024 aluminum sheet and plate for KC-135 aging aircraft body skin samples utilizing optical (light) metallography, scanning electron microscopy, and transmission electron microscopy. A detailed analysis and comparison of precipitates within the grains and in the grain boundaries were performed, as well as an examination of elemental depletion profiles across grain boundaries. These observations suggest that corrosion-related anodic sites play a far less significant role in the propagation of exfoliation than do the hard corrosion products creating wedging stresses within the elongated grain boundaries, which seem to demonstrate unique and unusual structural or energetic features or both.     

A new binary accelerator system for the sulfur vulcanization of natural rubber latex

Vulcanization of latex products are usually carried out at lower temperatures compared to dry rubber products. It has been suggested that, in latex vulcanization systems where thiourea is used as a secondary accelerator, it acts as a nucleophilic reagent facilitating the cleavage of the sulfur bonds in the primary accelerator like TMTD or CBS at lower temperature. But no conclusive proof is given to such a postulate. In the present study 1-phenyl-2,4-thiobiuret (DTB II) and 1,5-diphenyl-2,4-dithiobiuret (DTB III), which are more nucleophilic than thiourea and which vary in their nucleophilic reactivity, were studied as secondary accelerators along with tetramethyl thiuram disulphide (TMTD) and N-cyclohexylbenzothiazyl sulphenamide (CBS) in the vulcanization of natural rubber latex. These binary systems were found to be very effective in reducing the optimum vulcanization time. Also it was noted that 1-phenyl-2,4-dithiobiuret, which is more nucleophilic, is more reactive (as observed from the reduction in optimum cure time) as a secondary accelerator, indicating a nucleophilic reaction mechanism in the vulcanization reactions under review. The optimum dosages of the secondary accelerators required were derived. Physical properties like tensile strength, 300% modulus, and elongation at break of the latex vulcanizates were also studied. There is a definite advantage with respect to many of these properties for dithiobiuret systems compared to the systems containing TMTD alone or TMTD/thiourea. DTB III gives higher values in many of these physical properties than DTB II. Chemical characterization of the vulcanizates was also carried out to correlate the physical properties with the type of chemical crosslinks formed. © 1993 John Wiley & Sons, Inc.     

Cortical cholinergic impairment and behavioral deficits produced by kainic acid lesions of rat magnocellular basal forebrain.

The rat magnocellular basal forebrain (MNBF) is homologous to the human nucleus basalis of Meynert, a structure implicated in the cholinergic hypothesis of cognitive impairment in Alzheimer's disease (AD). In the present study, 18 male Sprague-Dawley rats with kainic acid lesions in the MNBF were compared with 6 unoperated controls, 10 sham-operated controls, and 6 controls injected with kainic acid in the cortical area directly above the MNBF. MNBF lesions depleted choline acetyltransferase in cortex but not in striatum or hippocampus. Cortical dopamine levels were unchanged; serotonin levels were unchanged in hippocampus and parietal cortex but decreased in frontal cortex. Compared with controls, MNBF-lesioned Ss were impaired in 24-hr retention, but not acquisition, of a passive avoidance task with escapable footshock. The groups did not differ in mean number of daily avoidances on a barpress active avoidance task, although learning was slower in MNBF-lesioned Ss. In a serial spatial discrimination reversal test, MNBF-lesioned Ss performed significantly worse than controls. This model may be useful for studying the role of the cholinergic system in memory and possibly for developing treatment strategies to alleviate the cognitive dysfunction of AD. (63 ref) (PsycINFO Database Record (c) 2010 APA, all rights reserved)     

Analysis of first ply failure in composite laminates

The mechanics of transverse cracking in an elastic fibrous composite ply is explored for the case of low crack density. Cracks are assumed to initiate from a nucleus created by localized fiber debonding and matrix cracking. It is found that cracks may propagate in two directions on planes which are parallel to the fiber axis and perpendicular to the midplane of the ply. In general, crack propagation in the direction of the fiber axis controls the strength of thin plies, while cracking in the direction perpendicular to the fiber axis determines the strength of thick plies. The theory relates ply thickness, crack geometry and ply toughness to ply strength. It predicts a significant increase in strength with decreasing ply thickness in constrained thin plies. The strength of thick plies is found to be constant, but it may be reduced by preexisting damage. Results are illustrated by comparison with experimental data.     

Distribution of diethylstilboestrol in pigs

The synthetic growth promoter diethylstilboestrol (DES) administered orally to pigs can be detected by radioimmunoassay (RIA) analysis of kidney, liver, faeces, bile and urine from animals fed continuously to slaughter, but not in muscle, fat or plasma. If treated animals are fed on material not containing DES for 72 h prior to slaughter, then the levels of parent compound and metabolite in all products decrease to become not significantly greater than those in control animals. The gross metabolism of DES in pigs and bovines appears to be similar.     

Stress and stability analysis of toroidal shells

A finite element formulation applicable to the general shell of revolution is presented for the stress and stability analysis of toroidal pressure vessels under hydrostatic pressure. Considering the follower force effect of the external pressure, linear bifurcation buckling loads and corresponding mode shapes have been obtained in both axially and equatorially symmetric as well as antisymmetric buckling modes. Calculated critical values are compared with results of other investigations.     

Induction of early atherosclerosis in LDL-receptor-deficient mice immunized with beta2-glycoprotein I

BACKGROUND: Immunization with beta2-glycoprotein I (beta2GPI), the probable target of autoimmune anticardiolipin antibodies, results in experimental antiphospholipid syndrome in different mouse strains. The present study was undertaken to evaluate the effect of beta2GPI immunization on the progression of atherosclerosis. METHODS AND RESULTS: In the first experiment, 3 groups of LDL receptor-deficient (LDL-RD) mice (n=15 per group) were immunized with either beta2GPI or ovalbumin or were not immunized and were fed a chow diet for 12 weeks. In a second experiment, 3 groups of LDL-RD mice (n=10 per group) were immunized similarly and fed an atherogenic diet for 6 weeks. All beta2GPI-immunized mice developed high titers of anti-beta2GPI antibodies as well as a specific lymph node proliferation to beta2GPI. The average cholesterol levels did not differ between the mice fed similar diets, regardless of the immunization protocol. Atherosclerosis was enhanced in the beta2GPI-immunized mice (mean aortic lesion, 26 000+/-5700 microm2) in comparison with their ovalbumin-immunized (mean, 3000+/-1099 microm2; P<0.01) and nonimmunized (mean, 2250+/-700 microm2; P<0.01) littermates. The average lesion size in the beta2GPI-immunized mice fed an atherogenic diet (mean, 98 000+/-8305 microm2) was larger than the ovalbumin-immunized mice (mean, 81 250+/-12 933 microm2; P=NS) or the nonimmunized controls (mean, 75 625+/-7281 microm2; P=NS). The atherosclerotic plaques in the beta2GPI-immunized mice appeared to be more mature, and denser infiltration of CD4 lymphocytes was present in the subendothelium of the aortic sinuses from this group of mice. CONCLUSIONS: The results of the present study provide the first direct evidence for the proatherogenic effect of ss2GPI immunization and establish a new model for immune-mediated atherosclerosis.     

A randomized controlled trial of filgrastim during remission induction and consolidation chemotherapy for adults with acute lymphoblastic leukemia: CALGB study 9111

Recombinant human granulocyte colony-stimulating factor (G-CSF; filgrastim) shortens the time to neutrophil recovery after intensive chemotherapy, but its role in the treatment of adults with acute lymphoblastic leukemia (ALL) is uncertain. We randomly assigned 198 adults with untreated ALL (median age, 35 years; range, 16 to 83) to receive either placebo or G-CSF (5 microgram/kg/d) subcutaneously, beginning 4 days after starting intensive remission induction chemotherapy and continuing until the neutrophil count was >/=1, 000/microL for 2 days. The study assignment was unblinded as individual patients achieved a complete remission (CR). Patients initially assigned to G-CSF then continued to receive G-CSF through 2 monthly courses of consolidation therapy. Patients assigned to placebo received no further study drug. The median time to recover neutrophils >/=1,000/microL during the remission induction course was 16 days (interquartile range [IQR], 15 to 18 days) for the patients assigned to receive G-CSF and 22 days (IQR, 19 to 29 days) for the patients assigned to placebo (P < .001). Patients in the G-CSF group had significantly shorter durations of neutropenia (<1, 000/microL) and thrombocytopenia (<50,000/microL) and fewer days in the hospital (median, 22 days v 28 days; P = .02) compared with patients receiving placebo. The patients assigned to receive G-CSF had a higher CR rate and fewer deaths during remission induction than did those receiving placebo (P = .04 by the chi-square test for trend). During Courses IIA and IIB of consolidation treatment, patients in the G-CSF group had significantly more rapid recovery of neutrophils >/=1,000/microL than did the control group by approximately 6 to 9 days. However, the patients in the G-CSF group did not complete the planned first 3 months of chemotherapy any more rapidly than did the patients in the placebo group. Overall toxicity was not lessened by the use of G-CSF. After a median follow-up of 4. 7 years, there were no significant differences in either the disease-free survival (P = .53) or the overall survival (P = .25) for the patients assigned to G-CSF (medians, 2.3 years and 2.4 years, respectively) compared with those assigned to placebo (medians, 1.7 and 1.8 years, respectively). Adults who received intensive chemotherapy for ALL benefited from G-CSF treatment, but its use did not markedly affect the ultimate outcome.